SAN DIEGO, Sept. 15, 2026 /PRNewswire/ — The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in shares of Capricor Therapeutics, Inc. (NASDAQ: CAPR).
Investors who purchased shares of Capricor Therapeutics, Inc. (NASDAQ: CAPR) have certain options and there are short and strict deadlines running. Deadline: September 28, 2026. NASDAQ: CAPR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
On July 30, 2026, an investor in NASDAQ: CAPR shares filed lawsuit against Capricor Therapeutics, Inc over alleged securities laws violations.
The lawsuit seeks to recover losses for certain investors.
The plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that Capricor Therapeutics, Inc. adopted changes to the pre-specified statistical analysis plan used to analyze clinical data for Deramiocel, that the FDA had not agreed to those changes before Capricor Therapeutics, Inc. resubmitted the Deramiocel Biologics License Application (“BLA”), that as a result, there was a significant risk that the FDA could conclude the clinical results did not provide substantial evidence of effectiveness of Deramiocel, and that as a result of the foregoing, there was a substantial risk to regulatory approval of Deramiocel for the treatment of Duchenne muscular dystrophy.
Those who purchased shares of Capricor Therapeutics, Inc. (NASDAQ: CAPR) should contact the Shareholders Foundation, Inc.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nasdaq-capr-lawsuit-alert-investors-who-lost-money-with-shares-of-capricor-therapeutics-incshould-contact-the-shareholders-foundation-302878844.html
SOURCE Shareholders Foundation, Inc.
